CryoLife Receives American Association of Tissue Banks (AATB) Accreditation
February 01 2005 - 8:30AM
PR Newswire (US)
CryoLife Receives American Association of Tissue Banks (AATB)
Accreditation ATLANTA, Feb. 1 /PRNewswire-FirstCall/ -- CryoLife,
Inc. (NYSE:CRY), a biomaterials and biosurgical device company,
announced today that it received accreditation from the American
Association of Tissue Banks (AATB). The AATB is a scientific,
not-for-profit peer group organization that facilitates the
provision of high quality transplantable human tissues in
quantities sufficient to meet national needs. "CryoLife is pleased
to join the AATB, which is highly regarded and recognized within
the tissue banking industry and medical community. For over twenty
years, CryoLife has served as a technological bridge between donor
families and allograft recipients. CryoLife is dedicated to
improving the health and quality of life around the world through
tissue transplantation and its biosurgical adhesive, BioGlue. Since
the Company was founded in 1984, more than 100,000
CryoLife-processed human tissues have been implanted in patients,"
said Steven G. Anderson, CryoLife President and Chief Executive
Officer. "CryoLife is one of the largest tissue processors in the
country with an extensive history of providing innovative tissue
technologies to the transplant community and we welcome them as a
member of the AATB," stated P. Robert Rigney, Jr., J.D., Chief
Executive Officer of AATB. Founded in 1984, CryoLife, Inc. is a
leader in the processing and distribution of implantable living
human tissues for use in cardiovascular and vascular surgeries
throughout the United States and Canada. The Company's BioGlue(R)
Surgical Adhesive is FDA approved as an adjunct to sutures and
staples for use in adult patients in open surgical repair of large
vessels, and is CE marked in the European Community and approved in
Canada for use in soft tissue repair and approved in Australia for
use in vascular and pulmonary sealing and repair. The Company also
manufactures the SG Model #100 vascular graft, which is CE marked
for distribution within the European Community. Contact: Joseph T.
Schepers Vice President, Corporate Communications (770) 419-3355
DATASOURCE: CryoLife, Inc. CONTACT: Joseph T. Schepers, Vice
President, Corporate Communications of CryoLife, Inc.,
+1-770-419-3355 Web site: http://www.cryolife.com/
Copyright
CryoLife (NYSE:CRY)
Historical Stock Chart
From Jun 2024 to Jul 2024
CryoLife (NYSE:CRY)
Historical Stock Chart
From Jul 2023 to Jul 2024